{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T13:20:20Z","timestamp":1794576020498,"version":"4.9.1"},"reference-count":36,"publisher":"BMJ","issue":"8","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neurology, Neurosurgery &amp; Psychiatry"],"published-print":{"date-parts":[[2014,8,1]]},"DOI":"10.1136\/jnnp-2013-306787","type":"journal-article","created":{"date-parts":[[2014,1,17]],"date-time":"2014-01-17T02:49:55Z","timestamp":1389926995000},"page":"840-844","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":239,"title":["Impulse control disorder in patients with Parkinson's disease under dopamine agonist therapy: a multicentre study"],"prefix":"10.1136","volume":"85","author":[{"given":"P. J.","family":"Garcia-Ruiz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. C.","family":"Martinez Castrillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Alonso-Canovas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Herranz Barcenas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Vela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Sanchez Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Mata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Olmedilla Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Mahillo Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2014,1,16]]},"reference":[{"key":"key-10.1136\/jnnp-2013-306787-1","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/archneur.63.7.969","article-title":"Association of dopamine agonist use with impulse control disorders in Parkinson disease","volume":"63","author":"Weintraub","year":"2006","journal-title":"Arch Neurol"},{"key":"key-10.1136\/jnnp-2013-306787-2","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/1531-8257(200009)15:5<869::AID-MDS1016>3.0.CO;2-I","article-title":"Pathologic gambling in Parkinson's disease: a behavioral manifestation of pharmacologic treatment?","volume":"15","author":"Molina","year":"2000","journal-title":"Mov Disord"},{"key":"key-10.1136\/jnnp-2013-306787-3","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.parkreldis.2007.05.006","article-title":"Predictors of impulsivity and reward seeking behavior with dopamine agonists","volume":"14","author":"Ondo","year":"2008","journal-title":"Parkinsonism Relat Disord"},{"key":"key-10.1136\/jnnp-2013-306787-4","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/S1474-4422(09)70287-X","article-title":"Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders","volume":"8","author":"Voon","year":"2009","journal-title":"Lancet Neurol"},{"key":"key-10.1136\/jnnp-2013-306787-5","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1001\/archneurol.2010.65","article-title":"Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients","volume":"67","author":"Weintraub","year":"2010","journal-title":"Arch Neurol"},{"key":"key-10.1136\/jnnp-2013-306787-6","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/mds.25291","article-title":"Prospective cohort study of impulse control disorders in Parkinson's disease","volume":"28","author":"Bastiaens","year":"2013","journal-title":"Mov Disord"},{"key":"key-10.1136\/jnnp-2013-306787-7","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jns.2011.07.031","article-title":"Clinical aspects of impulsive compulsive behaviours in Parkinson's disease","volume":"310","author":"Djamshidian","year":"2011","journal-title":"J Neurol Sci"},{"key":"key-10.1136\/jnnp-2013-306787-8","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/WNF.0b013e31826e6e6d","article-title":"Prevalence and pharmacological factors associated with impulse-control disorder symptoms in patients with Parkinson disease","volume":"35","author":"Perez-Lloret","year":"2012","journal-title":"Clin Neuropharmacol"},{"key":"key-10.1136\/jnnp-2013-306787-9","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.parkreldis.2013.02.007","article-title":"Pathological gambling in Parkinson's disease. A comprehensive review","volume":"19","author":"Santangelo","year":"2013","journal-title":"Parkinsonism Relat Disord"},{"key":"key-10.1136\/jnnp-2013-306787-10","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1002\/1531-8257(199909)14:5<836::AID-MDS1018>3.0.CO;2-0","article-title":"Punding on L-dopa","volume":"14","author":"Fernandez","year":"1999","journal-title":"Mov Disord"},{"key":"key-10.1136\/jnnp-2013-306787-11","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1136\/jnnp.68.4.423","article-title":"Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies","volume":"68","author":"Giovannoni","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key-10.1136\/jnnp-2013-306787-12","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/mds.20046","article-title":"Repetition, repetition, and repetition: compulsive and punding behaviors in Parkinson's disease","volume":"19","author":"Voon","year":"2004","journal-title":"Mov Disord"},{"key":"key-10.1136\/jnnp-2013-306787-13","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.parkreldis.2005.02.009","article-title":"Increased writing activity in Parkinson's disease: a punding-like behavior?","volume":"11","author":"Miwa","year":"2005","journal-title":"Parkinsonism Relat Disord"},{"key":"key-10.1136\/jnnp-2013-306787-14","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/mds.20757","article-title":"Compulsive eating and weight gain related to dopamine agonist use","volume":"21","author":"Nirenberg","year":"2006","journal-title":"Mov Disord"},{"key":"key-10.1136\/jnnp-2013-306787-15","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1002\/mds.20787","article-title":"Punding and computer addiction in Parkinson's disease","volume":"21","author":"Fasano","year":"2006","journal-title":"Mov Disord"},{"key":"key-10.1136\/jnnp-2013-306787-16","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jns.2011.07.012","article-title":"Dopaminergic dysregulation syndrome in Parkinson's disease","volume":"310","author":"Katzenschlager","year":"2011","journal-title":"J Neurol Sci"},{"key":"key-10.1136\/jnnp-2013-306787-17","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00415-012-6645-9","article-title":"Clinical characteristics of impulse control and repetitive behavior disorders in Parkinson's disease","volume":"260","author":"Kim","year":"2013","journal-title":"J Neurol"},{"key":"key-10.1136\/jnnp-2013-306787-18","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1002\/mds.22571","article-title":"Validation of the questionnaire for impulsive-compulsive disorders in Parkinson's disease","volume":"24","author":"Weintraub","year":"2009","journal-title":"Mov Disord"},{"key":"key-10.1136\/jnnp-2013-306787-19","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.parkreldis.2012.11.008","article-title":"Impulse control disorders induced by rasagiline as adjunctive therapy for Parkinson's disease: report of 2 cases","volume":"19","author":"Vitale","year":"2013","journal-title":"Parkinsonism Relat Disord"},{"key":"key-10.1136\/jnnp-2013-306787-20","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s00228-011-1198-x","article-title":"Do Parkinson's disease patients disclose their adverse events spontaneously?","volume":"68","author":"Perez-Lloret","year":"2001","journal-title":"Eur J Clin Pharmacol"},{"key":"key-10.1136\/jnnp-2013-306787-21","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1002\/mds.20210","article-title":"Switching from ergot to nonergot dopamine agonists in Parkinson's disease: a clinical series and five-drug dose conversion table","volume":"19","author":"Grosset","year":"2004","journal-title":"Mov Disord"},{"key":"key-10.1136\/jnnp-2013-306787-22","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1007\/s00415-003-1086-0","article-title":"S. Dual dopamine agonist treatment in Parkinson's disease","volume":"250","author":"Stocchi","year":"2003","journal-title":"J Neurol"},{"key":"key-10.1136\/jnnp-2013-306787-23","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases","volume":"55","author":"Hughes","year":"1992","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key-10.1136\/jnnp-2013-306787-24","first-page":"285","article-title":"Assessment of Parkinson's disease","volume-title":"Quantification of Neurological deficit","author":"Lang","year":"1989"},{"key":"key-10.1136\/jnnp-2013-306787-25","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1002\/mds.23429","article-title":"Systematic review of levodopa dose equivalency reporting in Parkinson's disease","volume":"25","author":"Tomlinson","year":"2010","journal-title":"Mov Disord"},{"key":"key-10.1136\/jnnp-2013-306787-26","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1212\/WNL.0b013e31827b915c","article-title":"Parkinson's Progression Markers Initiative. Screening for impulse control symptoms in patients with de novo Parkinson disease: a case-control study","volume":"80","author":"Weintraub","year":"2013","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2013-306787-27","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/WNF.0b013e3181684542","article-title":"Impulse control disorders arising in 3 patients treated with rotigotine","volume":"32","author":"Wingo","year":"2009","journal-title":"Clin Neuropharmacol"},{"key":"key-10.1136\/jnnp-2013-306787-28","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1517\/14740338.2012.678830","article-title":"Drug safety evaluation of rotigotine","volume":"11","author":"Sprenger","year":"2012","journal-title":"Expert Opin Drug Saf"},{"key":"key-10.1136\/jnnp-2013-306787-29","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.parkreldis.2010.11.015","article-title":"Patient versus informant reporting of ICD symptoms in Parkinson's disease using the QUIP: validity and variability","volume":"17","author":"Papay","year":"2011","journal-title":"Parkinsonism Relat Disord"},{"key":"key-10.1136\/jnnp-2013-306787-30","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/mds.25105","article-title":"Decision making, impulsivity, and addictions: do Parkinson's disease patients jump to conclusions?","volume":"27","author":"Djamshidian","year":"2012","journal-title":"Mov Disord"},{"issue":"(Suppl 4)","key":"key-10.1136\/jnnp-2013-306787-31","first-page":"36","article-title":"Ergoline and non-ergoline derivatives in the treatment of Parkinson's disease","volume":"253","author":"Reichmann","year":"2006","journal-title":"J Neurol"},{"key":"key-10.1136\/jnnp-2013-306787-32","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1002\/mds.21741","article-title":"AH. Rotigotine transdermal patch in early Parkinson's disease: a randomized, double-blind, controlled study versus placebo and ropinirole","volume":"22","author":"Giladi","year":"2007","journal-title":"Mov Disord"},{"key":"key-10.1136\/jnnp-2013-306787-33","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S1474-4422(09)70225-X","article-title":"A reassessment of risks and benefits of dopamine agonists in Parkinson's disease","volume":"8","author":"Antonini","year":"2009","journal-title":"Lancet Neurol"},{"key":"key-10.1136\/jnnp-2013-306787-34","doi-asserted-by":"crossref","first-page":"941","DOI":"10.2165\/11537810-000000000-00000","article-title":"Dopamine receptor agonists for the treatment of early or advanced Parkinson's disease","volume":"24","author":"Perez-Lloret","year":"2010","journal-title":"CNS Drugs"},{"key":"key-10.1136\/jnnp-2013-306787-35","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1517\/14656560902746041","article-title":"Rotigotine transdermal delivery for the treatment of Parkinson's disease","volume":"10","author":"Rascol","year":"2009","journal-title":"Expert Opin Pharmacother"},{"key":"key-10.1136\/jnnp-2013-306787-36","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.tips.2010.12.003","article-title":"Recent advances in the search for D3- and D4-selective drugs: probes, models and candidates","volume":"32","author":"L\u00f6ber","year":"2011","journal-title":"Trends Pharmacol Sci"}],"container-title":["Journal of Neurology, Neurosurgery &amp; Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp-2013-306787","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T17:55:11Z","timestamp":1601056511000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp-2013-306787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,16]]},"references-count":36,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2014,7,9]]},"published-print":{"date-parts":[[2014,8,1]]}},"URL":"https:\/\/doi.org\/10.1136\/jnnp-2013-306787","relation":{},"ISSN":["0022-3050"],"issn-type":[{"value":"0022-3050","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1,16]]}}}